{"transactions":[{"id":1686966,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":95459,"kind":"person","name":"Mahatme Ujwala","position":1,"cik":"0001823894","reported_name":"Mahatme Ujwala","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T21:22:08.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":52575,"price":1.32,"value":69399.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $69,400."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on January 2, 2024. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the director remaining as a non-salaried director on each such vesting date."}],"balance_after":87575,"derivative":{"exercise_price":2.64,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":52575},"source":{"system":"sec-edgar","filing":"0001599298-24-000010","document":"wk-form4_1704403313.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929824000010/wk-form4_1704403313.xml","form_type":"4"}},{"id":1686965,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":95459,"kind":"person","name":"Mahatme Ujwala","position":1,"cik":"0001823894","reported_name":"Mahatme Ujwala","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T21:22:08.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 2, 2024. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-salaried director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":2.64,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001599298-24-000010","document":"wk-form4_1704403313.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929824000010/wk-form4_1704403313.xml","form_type":"4"}},{"id":2061707,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":95459,"kind":"person","name":"Mahatme Ujwala","position":1,"cik":"0001823894","reported_name":"Mahatme Ujwala","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-05T21:14:55.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":40500,"price":1.67,"value":67635.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $67,500."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was issued on January 3, 2023. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the director remaining as a non-employee director on each such vesting date."}],"balance_after":75500,"derivative":{"exercise_price":5,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":40500},"source":{"system":"sec-edgar","filing":"0001599298-23-000006","document":"wf-form4_167295328081339.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929823000006/wf-form4_167295328081339.xml","form_type":"4"}},{"id":2061706,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":95459,"kind":"person","name":"Mahatme Ujwala","position":1,"cik":"0001823894","reported_name":"Mahatme Ujwala","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-05T21:14:55.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 3, 2023. The shares underlying the option shall vest in four equal annual installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-employee director on each such vesting date."}],"balance_after":35000,"derivative":{"exercise_price":5,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001599298-23-000006","document":"wf-form4_167295328081339.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929823000006/wf-form4_167295328081339.xml","form_type":"4"}},{"id":2442786,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":95459,"kind":"person","name":"Mahatme Ujwala","position":1,"cik":"0001823894","reported_name":"Mahatme Ujwala","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-05T21:05:43.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":47872,"price":1.13,"value":54095.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $54,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was issued on January 3, 2022. The shares underlying the option are scheduled to vest in four equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022."}],"balance_after":72872,"derivative":{"exercise_price":2.82,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":47872},"source":{"system":"sec-edgar","filing":"0001599298-22-000007","document":"wf-form4_164141670774490.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929822000007/wf-form4_164141670774490.xml","form_type":"4"}},{"id":2442785,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":95459,"kind":"person","name":"Mahatme Ujwala","position":1,"cik":"0001823894","reported_name":"Mahatme Ujwala","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-05T21:05:43.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 3, 2022. The shares underlying the option are scheduled to vest in equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022."}],"balance_after":25000,"derivative":{"exercise_price":2.82,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001599298-22-000007","document":"wf-form4_164141670774490.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929822000007/wf-form4_164141670774490.xml","form_type":"4"}},{"id":2838098,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":95459,"kind":"person","name":"Mahatme Ujwala","position":1,"cik":"0001823894","reported_name":"Mahatme Ujwala","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-02-23T22:55:39.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on February 19, 2021. The shares underlying the option are scheduled to vest in full on December 31, 2021."}],"balance_after":238340,"derivative":{"exercise_price":7.33,"exercise_date":"2021-12-31","expiration_date":"2031-02-19","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000921895-21-000542","document":"form412566uja_02232021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000092189521000542/form412566uja_02232021.xml","form_type":"4"}}]}